GSK to post all clinical trial information on drugs it sells

06/20/2004 | NYTimes.com

GlaxoSmithKline, widely criticized for its handling of information about its major antidepressant drug, Paxil, announced it will post clinical trials results for all its marketed drugs on a company Web site. GSK said the site will include results of all tests run on a drug before its approval, as well as any additional tests devised for new uses after a drug goes to market. Last week, the company posted on its site all test reports on Paxil and its effect on children and adolescents, including indications it caused suicidal tendencies in some patients, and indicated it would expand the move to include other drugs.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC